Imatinib Use Either Pre- Or Post-Allogeneic Hematopoietic Cell Transplantation (Allo-Hct) Does Not Increase Cardiac Toxicity in Chronic Myelogenous Leukemia Patients

Bone Marrow Transplantation - United Kingdom
doi 10.1038/bmt.2008.441
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC